ChemicalBook > Product Catalog >API >Circulatory system drugs >Lipid regulating drugs >S-3013

S-3013

S-3013 Suppliers list
Company Name: SPIRO PHARMA  
Tel:
Email: eric_feng1954@126.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: ChengDu TongChuangYuan Pharmaceutical Co.Ltd  
Tel: 028-83379370 13880556291
Email: tcy@tcypharm.com
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 17801761073 18101056239
Email: 3193328036@qq.com
Company Name: Kaixin Chemical (Hong Kong) Limited  
Tel: 010-88886666-01 13112345678
Email: loyson@qq.com

S-3013 manufacturers

S-3013 Basic information
Product Name:S-3013
Synonyms:A-002;S-3013;Acetic acid, 2-[[3-(2-amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester;inhibit,Phospholipase,Inhibitor,A002,Varespladib methyl,LY 333013,LY-333013,A 002;methyl 2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetate;VARESPLADIB METHYL (LY333013);Varespladib methyl, 10 mM in DMSO;Varespladib Methyl
CAS:172733-08-3
MF:C22H22N2O5
MW:394.42
EINECS:
Product Categories:
Mol File:172733-08-3.mol
S-3013 Structure
S-3013 Chemical Properties
Melting point 172-187 °C
Boiling point 624.6±65.0 °C(Predicted)
density 1.26±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 100 mg/mL (253.54 mM)
form Solid
pka12+-.0.50(Predicted)
color White to off-white
Safety Information
MSDS Information
S-3013 Usage And Synthesis
UsesVarespladib methyl (A-002; LY333013) is a selective inhibitor of group II secretory phospholipase A2 (PLA2).
DefinitionChEBI: Varespladib methyl is a methyl ester resulting from the formal condensation of the carboxy group of varespladib with methanol. It is a potential therapy for the treatment of snakebite envenomings in which toxicity depends on the action of PLA2s. It has a role as a prodrug, an anti-inflammatory drug, an antidote and an EC 3.1.1.4 (phospholipase A2) inhibitor. It is a methyl ester, an aromatic ether, a member of benzenes, a member of indoles and a primary carboxamide. It is functionally related to a varespladib.
References[1] Bradley JD, et al. A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J Rheumatol. 2005 Mar;32(3):417-23. PMID:15742431
[2] Lewin M, et al. Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation. Toxins (Basel). 2016 Aug 25;8(9). pii: E248. DOI:10.3390/toxins8090248
S-3013 Preparation Products And Raw materials
Preparation ProductsNatrium[(1-benzyl-2-ethyl-3-oxamoylindool-4-yl)oxy]acetaat
Tag:S-3013(172733-08-3) Related Product Information
Natrium[(1-benzyl-2-ethyl-3-oxamoylindool-4-yl)oxy]acetaat VARESPLADIB Acetic acid, 2-[[3-(2-amino-2-oxoacetyl)-1-([1,1'-biphenyl]-2-ylmethyl)-2-methyl-1H-indol-4-yl]oxy]- S-3013 EC 3.1.4.4 TYPE IV DARAPLADIB